PRESS RELEASE published on 07/22/2025 at 07:00, 1 year 2 months ago Sartorius continues growth course; earnings rise at a significantly overproportionate rate Sartorius AG reports continued growth with significant increase in earnings for the first half of 2025. Group's sales revenue up 6.1%. CEO confirms guidance for the full year 2025 Sales Revenue Growth Earnings Sartorius AG Guidance
BRIEF published on 07/01/2025 at 17:35, 1 year 3 months ago Sartorius finalise l'acquisition de MatTek Acquisition Sartorius Développement De Médicaments MatTek Technologie Cellulaire
BRIEF published on 07/01/2025 at 17:35, 1 year 3 months ago Sartorius Finalizes Acquisition of MatTek Acquisition Sartorius Drug Development MatTek Cell Technology
PRESS RELEASE published on 07/01/2025 at 17:30, 1 year 3 months ago Sartorius completes acquisition of MatTek Sartorius completes acquisition of MatTek from BICO Group AB, expanding its cell technology portfolio and creating synergies with existing solutions for drug development Acquisition Sartorius Drug Development MatTek Cell Technology
BRIEF published on 05/02/2025 at 09:27, 1 year 5 months ago Sartorius Extends Executive Board Tenure for Alexandra Gatzemeyer Executive Board Sartorius AG Biopharmaceutical Industry Alexandra Gatzemeyer Lab Products
BRIEF published on 05/02/2025 at 09:27, 1 year 5 months ago Sartorius prolonge le mandat d'Alexandra Gatzemeyer au conseil d'administration Sartorius AG Industrie Biopharmaceutique Conseil Exécutif Alexandra Gatzemeyer Produits De Laboratoire
PRESS RELEASE published on 05/02/2025 at 09:22, 1 year 5 months ago Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer Sartorius AG extends Dr. Alexandra Gatzemeyer's Executive Board appointment until 2031, responsible for Lab Products & Services Division Executive Board Sartorius AG Appointment Extension Alexandra Gatzemeyer Lab Products & Services Division
BRIEF published on 04/16/2025 at 07:04, 1 year 6 months ago Sartorius annonce un bon début de premier trimestre 2025 Croissance Des Ventes Sartorius AG Marge D'EBITDA Premier Trimestre 2025 Solutions De Bioprocédés
BRIEF published on 04/16/2025 at 07:04, 1 year 6 months ago Sartorius Reports Strong Start in 2025 First Quarter EBITDA Margin Sales Growth Sartorius AG First Quarter 2025 Bioprocess Solutions
PRESS RELEASE published on 04/16/2025 at 06:59, 1 year 6 months ago Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Sartorius AG achieves significant profitable growth in the first quarter of 2025 with a 6.5% increase in group sales revenue and a strong start in consumables business Profitable Growth Sales Revenue Sartorius AG First Quarter Consumables Business
Published on 10/21/2026 at 13:15, 8 minutes ago Gemdale Gold Completes Phase 2 2026 Drill Program at its Pontio Gold Project, Finland
Published on 10/21/2026 at 13:00, 23 minutes ago Rocky Shore Gold Engages Independent Trading Group as Market Maker
Published on 10/21/2026 at 13:00, 23 minutes ago North Sky Metals Commences Trading on the TSX Venture Exchange Under Symbol "NSKY"
Published on 10/21/2026 at 13:00, 23 minutes ago First Canadian Graphite Inc. Announces $3M Financing
Published on 10/21/2026 at 13:05, 18 minutes ago Rockwell Automation Introduces FactoryTalk Conductor, an AI-Native Orchestration Platform for Industrial Automation
Published on 10/21/2026 at 13:00, 23 minutes ago Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Published on 10/21/2026 at 12:10, 1 hour 12 minutes ago ESTEVE CDMO strengthens its global manufacturing footprint with a major investment and new site in China
Published on 10/21/2026 at 12:00, 1 hour 23 minutes ago MC Services to Support BIO-Europe® 2026 in Cologne as Media Partner
Published on 10/21/2026 at 12:00, 1 hour 23 minutes ago Linde Expands Supply of Industrial Gases to Tata Steel in India
Published on 10/21/2026 at 07:00, 6 hours 23 minutes ago Edenred affiche une croissance solide sur les neuf premiers mois de 2026 et confirme ses objectifs pour l’année
Published on 10/21/2026 at 07:00, 6 hours 23 minutes ago Edenred reports sound growth in the first nine months of 2026 and confirms its guidance for the full year
Published on 10/21/2026 at 07:00, 6 hours 23 minutes ago Chiffre d'affaires 3ème trimestre 2026 : 265,5 M€ (+4,8 %)
